Literature DB >> 17101032

Multiple sclerosis: a battle between destruction and repair.

Jonathan L McQualter1, Claude C A Bernard.   

Abstract

Multiple sclerosis (MS) is a chronic neurodegenerative disease of the CNS in which an unrelenting attack from the innate and adaptive arms of the immune system results in extensive demyelination, loss of oligodendrocytes and axonal degeneration. This review summarizes advances in the understanding of the cellular and molecular pathways involved in neurodegeneration following autoimmune-mediated inflammation in the CNS. The mechanisms underlying myelin and axonal destruction and the equally important interaction between degenerative and repair mechanisms are discussed. Recent studies have revealed that the failure of CNS regeneration may be in part a result of the presence of myelin-associated growth inhibitory molecules in MS lesions. Successful therapeutic intervention in MS is likely to require suppression of the inflammatory response, in concert with blockade of growth inhibitory molecules and possibly the mobilization or transplantation of stem cells for regeneration.

Entities:  

Mesh:

Year:  2006        PMID: 17101032     DOI: 10.1111/j.1471-4159.2006.04232.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  30 in total

Review 1.  New insights into signaling during myelination in zebrafish.

Authors:  Alya R Raphael; William S Talbot
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

2.  Quantitative and phenotypic analysis of bone marrow-derived cells in the intact and inflamed central nervous system.

Authors:  Martin A Short; Naomi Campanale; Sara Litwak; Claude C A Bernard
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

Review 3.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

4.  Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.

Authors:  Giuseppe Mameli; Luciana Poddighe; Alessandra Mei; Elena Uleri; Stefano Sotgiu; Caterina Serra; Roberto Manetti; Antonina Dolei
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

5.  Emerging roles of p53 in glial cell function in health and disease.

Authors:  Joseph D Jebelli; Claudie Hooper; Gwenn A Garden; Jennifer M Pocock
Journal:  Glia       Date:  2011-11-21       Impact factor: 7.452

Review 6.  Phytotherapy as a Complementary Medicine for Multiple Sclerosis.

Authors:  Zahra Rabiei
Journal:  Turk J Pharm Sci       Date:  2019-03-27

Review 7.  The evidence for a beneficial role of vitamin A in multiple sclerosis.

Authors:  Yara Dadalti Fragoso; Patrick N Stoney; Peter J McCaffery
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

Review 8.  T-cell regulation by CD46 and its relevance in multiple sclerosis.

Authors:  Anne L Astier
Journal:  Immunology       Date:  2008-04-02       Impact factor: 7.397

9.  Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated.

Authors:  Beatriz G Pérez-Nievas; Borja García-Bueno; José L M Madrigal; Juan C Leza
Journal:  J Neuroinflammation       Date:  2010-10-07       Impact factor: 8.322

10.  Differentiation of C2D macrophage cells after adoptive transfer.

Authors:  Betsey E Potts; Marcia L Hart; Laura L Snyder; Dan Boyle; Derek A Mosier; Stephen K Chapes
Journal:  Clin Vaccine Immunol       Date:  2007-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.